GLUE — MONTE ROSA THERAPEUTICS INC

Ownership history in BVF INC/IL  ·  5 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in MONTE ROSA THERAPEUTICS INC (GLUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.02% (2025 Q4)
Avg. % of fund
1.27%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 3,835,886 -1,824,246 -32.2% 2.02% $60.1M $15.68
2025 Q3 UNCHANGED 5,660,132 — 0% 1.70% $41.9M $7.41
2025 Q2 UNCHANGED 5,660,132 — 0% 0.91% $25.5M $4.51
2025 Q1 ADDED 5,660,132 +2,895,661 +104.7% 1.07% $26.3M $4.64
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GLUE price (monthly, adj. close)

Other funds also holding GLUE

As of 2025 Q4 — sorted by position size

Versant Venture Management, LLC 3Y 7Y 45.49% NEA Management Company, LLC 3Y 7Y 6.15% Aisling Capital Management LP 3Y 7Y 4.82% TCG Crossover Management, LLC 3Y 2.4% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 2.24% MPM BioImpact LLC 3Y 2.11% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.08% Rangeley Capital, LLC 0.88% Parkwood LLC 3Y 7Y 0.86% BRAIDWELL LP 3Y 0.48%
← Back to BVF INC/IL Holdings